Literature DB >> 22674990

A vesiculovirus showing a steepened transcription gradient and dominant trans-repression of virus transcription.

Erin N Hodges1, Bianca S Heinrich, John H Connor.   

Abstract

Vesicular stomatitis virus (VSV) is a prototype nonsegmented, negative-sense virus used to examine viral functions of a broad family of viruses, including human pathogens. Here we demonstrate that S(2) VSV, an isolate with a small plaque phenotype compared to other Indiana strain viruses, has a transcription defect resulting in an altered pattern and rapid decline of transcription. The S(2) VSV transcription gradient is dominant over the wild-type transcription in a coinfection. This is the first characterization of an altered gradient of transcription not dependent on RNA template sequence or host response and may provide insight into new approaches to viral attenuation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674990      PMCID: PMC3421768          DOI: 10.1128/JVI.00358-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs.

Authors:  S A Moyer; G Abraham; R Adler; A K Banerjee
Journal:  Cell       Date:  1975-05       Impact factor: 41.582

2.  A VSV mutant synthesizes a large excess of functional mRNA but produces less viral protein than its wild-type parent.

Authors:  N L Davis; G W Wertz
Journal:  Virology       Date:  1980-05       Impact factor: 3.616

3.  Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription.

Authors:  J N Barr; S P Whelan; G W Wertz
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  D P Rhodes; S A Moyer; A K Banerjee
Journal:  Cell       Date:  1974-12       Impact factor: 41.582

6.  Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells.

Authors:  L P Villarreal; M Breindl; J J Holland
Journal:  Biochemistry       Date:  1976-04-20       Impact factor: 3.162

7.  Dominance of temperature-sensitive phenotypes. I. Studies of the mechanism of inhibition of the growth of wild-type vesicular stomatitis virus.

Authors:  J S Youngner; D W Frielle; P Whitaker-Dowling
Journal:  Virology       Date:  1986-11       Impact factor: 3.616

8.  The transcriptional form of the phosphoprotein of vesicular stomatitis virus is a trimer: structure and stability.

Authors:  Y Gao; N J Greenfield; D Z Cleverley; J Lenard
Journal:  Biochemistry       Date:  1996-11-19       Impact factor: 3.162

9.  Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription.

Authors:  L E Iverson; J K Rose
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

10.  Role of temperature-sensitive mutants in persistent infections initiated with vesicular stomatitis virus.

Authors:  J S Youngner; E J Dubovi; D O Quagliana; M Kelly; O T Preble
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more
  4 in total

1.  The structurally disordered paramyxovirus nucleocapsid protein tail domain is a regulator of the mRNA transcription gradient.

Authors:  Robert M Cox; Stefanie A Krumm; Vidhi D Thakkar; Maximilian Sohn; Richard K Plemper
Journal:  Sci Adv       Date:  2017-02-03       Impact factor: 14.136

2.  Investigating Macrophages Plasticity Following Tumour-Immune Interactions During Oncolytic Therapies.

Authors:  R Eftimie; G Eftimie
Journal:  Acta Biotheor       Date:  2019-08-13       Impact factor: 1.774

3.  Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages.

Authors:  Ziqi Zou; Mengyao Li; Yunlian Zhou; Jiaying Li; Ting Pan; Lihua Lai; Qingqing Wang; Lining Zhang; Qun Wang; Yinjing Song; Yuanyuan Zhang
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

4.  Newcastle disease virus genotype VII gene expression in experimentally infected birds.

Authors:  Phuong Thi Kim Doan; Wai Yee Low; Yan Ren; Rick Tearle; Farhid Hemmatzadeh
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.